213 related articles for article (PubMed ID: 2225598)
1. Uterine contractility during pregnancy and the effect of abortifacient drugs.
Bygdeman M; Swahn ML
Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):249-61. PubMed ID: 2225598
[TBL] [Abstract][Full Text] [Related]
2. Intrauterine administration of drugs for termination of pregnancy in the second trimester.
Toppozada M; Ismail AA
Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):327-49. PubMed ID: 2225603
[TBL] [Abstract][Full Text] [Related]
3. Biochemistry of myometrial contractility.
Egarter CH; Husslein P
Baillieres Clin Obstet Gynaecol; 1992 Dec; 6(4):755-69. PubMed ID: 1335853
[TBL] [Abstract][Full Text] [Related]
4. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
Swahn ML; Bygdeman M
Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
[TBL] [Abstract][Full Text] [Related]
5. Anti-progesterones for the interruption of pregnancy.
Bygdeman M; Van Look PF
Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
[TBL] [Abstract][Full Text] [Related]
7. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
Selinger M; Mackenzie IZ; Gillmer MD; Phipps SL; Ferguson J
Br J Obstet Gynaecol; 1987 Dec; 94(12):1218-22. PubMed ID: 3322376
[TBL] [Abstract][Full Text] [Related]
8. Medical methods to terminate early pregnancy.
Swahn ML; Bygdeman M
Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):293-306. PubMed ID: 2225601
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of RU 486.
Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive methods for termination of second trimester pregnancy.
Bygdeman M
Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):351-9. PubMed ID: 2225604
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
Bygdeman M; Swahn ML
Contraception; 1985 Jul; 32(1):45-51. PubMed ID: 4053605
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin F2 alpha, oxytocin, and uterine activation in hypertonic saline-induced abortions.
Fuchs AR; Rasmussen AB; Rehnström J; Toth M
Am J Obstet Gynecol; 1984 Sep; 150(1):27-32. PubMed ID: 6476024
[TBL] [Abstract][Full Text] [Related]
13. Uterine motility and cervical ripening in second trimester elective abortion by two different PGE analogues.
Di Lieto A; Catalano D; Albano G; Uccello N; Civetta A; Ferrara R; Fimiani R; Pontillo M; Paladini A
Clin Exp Obstet Gynecol; 1991; 18(4):251-9. PubMed ID: 1790608
[TBL] [Abstract][Full Text] [Related]
14. A study of the effect of mifepristone (antiprogesterone) followed by prostaglandin on uterine activity and fetal heart rate in patients having a termination of pregnancy.
Pulkkinen MO; Piiroinen O; Vainikka J
Arch Gynecol Obstet; 1989; 244(2):75-8. PubMed ID: 2712600
[TBL] [Abstract][Full Text] [Related]
15. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E
Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester termination with 16,16 dimethyl-PGE1-methyl ester (gemeprost), compared with a regimen that included intra-amniotic PGF2 alpha and hypertonic saline.
Waldron KW; Renou PM; Lolatgis N; Morris ND; Mamers PM; Oldham J; Healy DL
Reprod Fertil Dev; 1990; 2(5):495-8. PubMed ID: 2075246
[TBL] [Abstract][Full Text] [Related]
17. Uterine activity and placental histology in abortion at mid-trimester by rivanol and catheter.
Manabe Y; Manabe A; Yoshida Y
Acta Obstet Gynecol Scand; 1982; 61(5):433-7. PubMed ID: 6818827
[TBL] [Abstract][Full Text] [Related]
18. The current status of prostaglandins as abortifacients.
Brenner WE
Am J Obstet Gynecol; 1975 Oct; 123(3):306-28. PubMed ID: 810025
[TBL] [Abstract][Full Text] [Related]
19. [Artificial termination of pregnancy in late periods].
Nikonov AP
Akush Ginekol (Mosk); 1987 Oct; (10):7-10. PubMed ID: 3324784
[TBL] [Abstract][Full Text] [Related]
20. The physiology of cervical ripening and cervical dilatation and the effect of abortifacient drugs.
Uldbjerg N; Ulmsten U
Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):263-82. PubMed ID: 2225599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
